Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Alabama vs. Clemson in Sugar
Georgia vs. Oklahoma in Rose
OMG,,,you so smart!!!
That's what we count on you for BTW,,,just keeping it real!
See you at the Rose Bowl --- GO DAWGS!!!! And ONCI!!!!
You can contact the SEC and report Steve Berman for falsifying documents in an attempt to raise the PPS of ONCI.
Should they find your allegations true, they will file an injuction and shut down the entire operation. Steve Berman will stand trial and they could give him 5 - 8 years in prison.
I'am sure he had each and every one of those 74 'other OTC stocks'
He so smart.
I think it all comes down to whether you believe in the sales and revenues that the CEO talks about, or not! I am very long in this and think the sales are real. The CEO is real and the products' are real. I realize some don't.
Would I like the Financial Audit completed => yes
Would I like to hear the domicile issue is behind us now => yes
Would I like to hear that the stock issue is behind us => yes
In my opinion, you can wait for all of those items to be behind us,,,OR,,,pay a huge discount on the PPS now.
So, like I said ,,,it all comes down to whether you believe in the sales and the revenues that the CEO talks about,,,or not!!!
We are in a holding pattern at the present time. If that news about the Chinese Automaker hits the papers, you will be late to a big part of the party and chasing is a difficult pill to swallow.
Not if you bought in 1990 and sold in December 2006. You would have retired and living on easy street!
PhenixBleu,,,exactly right! The CEO would be a fool to put out false revenue expectations.
I love the lithium plays. Thanks.
Some BioPharm News:
StockNewsGazette- December 1st 2017
Northwest Biotherapeutics, Inc. (NWBO) vs. Cytori Therapeutics, Inc. (CYTX): Breaking Down the Biotechnology Industry’s Two Hottest Stocks
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) shares are up more than 32.16% this year and recently decreased -12.33% or -$0.04 to settle at $0.26. Cytori Therapeutics, Inc. (NASDAQ:CYTX), on the other hand, is down -78.15% year to date as of 11/28/2017. It currently trades at $0.33 and has returned -3.26% during the past week.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) and Cytori Therapeutics, Inc. (NASDAQ:CYTX) are the two most active stocks in the Biotechnology industry based on today’s trading volumes. To determine if one is a better investment than the other, we will compare the two companies’ growth, profitability, risk, return, and valuation characteristics, as well as their analyst ratings and sentiment signals.
Cash Flow
The value of a stock is simply the present value of its future free cash flows. NWBO’s free cash flow (“FCF”) per share for the trailing twelve months was -0.02. Comparatively, CYTX’s free cash flow per share was -0.12. On a percent-of-sales basis, NWBO’s free cash flow was -1.02% while CYTX converted -0.09% of its revenues into cash flow. This means that, for a given level of sales, CYTX is able to generate more free cash flow for investors.
Valuation
NWBO trades at a P/S of 125.39, compared to a P/B of 0.92, and a P/S of 1.36 for CYTX. NWBO is the cheaper of the two stocks on book value basis but is expensive in terms of P/E and P/S ratio. Given that earnings are what matter most to investors, analysts tend to place a greater weight on the P/E.
Analyst Price Targets and Opinions
A cheap stock isn’t a good investment if the stock is priced accurately. To get a sense of “value” we must compare the current price to some measure of intrinsic value such as a price target. NWBO is currently priced at a -94.8% to its one-year price target of 5.00. Comparatively, CYTX is -84.13% relative to its price target of 2.08. This suggests that NWBO is the better investment over the next year.
The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.00 for NWBO and 2.30 for CYTX, which implies that analysts are more bullish on the outlook for CYTX.
Insider Activity and Investor Sentiment
Analysts often look at short interest, or the percentage of a company’s float currently being shorted by investors, to aid in their outlook for a particular stock. NWBO has a short ratio of 7.38 compared to a short interest of 3.05 for CYTX. This implies that the market is currently less bearish on the outlook for CYTX.
Summary
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) beats Cytori Therapeutics, Inc. (NASDAQ:CYTX) on a total of 7 of the 14 factors compared between the two stocks. NWBO generates a higher return on investment, has higher cash flow per share and has lower financial risk. NWBO is more undervalued relative to its price target. Finally, CMLS has better sentiment signals based on short interest.
--------------------------------------------
Stock News Journal - Nov 30th 2017 Hesitation to buy this stock might leave you disappointed: MannKind Corporation (MNKD)
MannKind Corporation (NASDAQ:MNKD) market capitalization at present is $366.65M at the rate of $3.16 a share. The firm’s price-to-sales ratio was noted 16.86 in contrast with an overall industry average of 96.51. Most of the active traders and investors are keen to find ways to compare the value of stocks. The price-to-sales ratio offers a simple approach in this case. They just need to take the company’s market capitalization and divide it by the company’s total sales over the past 12 months. The lesser the ratio, the more attractive the investment. During the key period of last 5 years, MannKind Corporation (NASDAQ:MNKD) sales have annually surged 411.30% on average, however its earnings per share growth remained at 17.20%.
How Company Returns Shareholder’s Value?
Dividends is a reward scheme, that a company presents to its shareholders. There can be various forms of dividends, such as cash payment, stocks or any other form. This payment is usually a part of the profit of the company. A company’s dividend is mostly determined by its board of directors and it requires the shareholders’ approval. MannKind Corporation (NASDAQ:MNKD)for the trailing twelve months paying dividend with the payout ratio of 0.00% to its shareholders. Currently it is offering a dividend yield of 0.00% and a 5 year dividend growth rate of 0.00%. Over the last year Company’s shares have been trading in the range of $0.67 and $6.96. The stock is above its 52-week low with 374.33% and is in the wake of its 52-week high with -54.60%.
Performance & Technicalities
In the latest week MannKind Corporation (NASDAQ:MNKD) stock volatility was recorded 6.18% which for the previous full month was noted 8.78%. Meanwhile the stock weekly performance was subdued at -0.32%, which was down for the month at -6.23%. Likewise, the upbeat performance for the last quarter was 91.52% and for the full year it was 18.82%. Moreover the Company’s Year To Date performance was -0.74%. Now a days one of the fundamental indicator used in the technical analysis is called Stochastic %D”, Stochastic indicator was created by George Lane. The stochastic is a momentum indicator comparing the closing price of a security to the range of its prices over a fix period of time. The gauge is based on the assumption that if price surges, the closing price tends towards the values that belong to the upper part of the area of price movements in the preceding period. On the other hand if price drops, the contrary is right. For MannKind Corporation (NASDAQ:MNKD), Stochastic %D value stayed at 18.58% for the last 9 days. Considering more the value stands at 25.40% and 25.40% for 14 and 20 days, in that order.
-------------------------------------------
November 16th 2017 - Staff Writer
Rumor - Synergy Pharmaceuticals (SGYP) rejected Merck (MRK) latest offer as too low!
------------------------------------------
Finance Registar - November 16th 2017 CANNABIS BREAKOUT SPOTLIGHT ON OWC PHARMACEUTICAL RESEARCH CORP (OTCMKTS:OWCP)
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) broke out this week on a gigantic move. The stock is in a red-hot market space of late, and today’s breakout took shares above the 50-day simple moving average in a big way. The single-day move took it up 30% in a straight line on a jump in volume. For a little context, keep in mind that this thing is coming off a pullback from the $3/share level after trading under $0.02/share last Fall. So, it’s been a roller coaster ride over the past year. Wednesday’s move was one of the strongest we’ve seen out of shares of OWCP in the last six months. The move comes off a higher base of support around the $0.30 level, suggesting the stock is now possibly in the midst of a new and burgeoning upward trend.
Catalyzing Wednesday’s move, we saw 8K out of the company advertising changes to the Board of Directors for the added an experienced CPA. That’s always a good sign because it suggests the company’s finances are in order. The company also noted that it was granted a patent in Australia for proprietary cream for the treatment of skin disorders.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) casts itself as a company that engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It also provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations.
OWCP through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals, treatments and unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWC research is conducted at leading Israeli hospitals and scientific institutions and led by internationally renowned investigators.
OWCP’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. The company was formerly known as Dynamic Applications Corp. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Petach Tikva, Israel.
As noted above, shares of OWCP broke higher today in a feverish move that rocketed the stock up as much as 30%. The Cannabis patch has been on fire once again over the past month, and the company added fuel to the fire by beefing up its fiduciary team on the board as well as announcing some new global market IP value.
Ms. Hannah Feuer, Age 62, Director and Chairman of the Audit Committee: Ms. Feuer is a CPA and Senior CFO with more than 20 years of experience in capital markets and management in financial institutions. During Ms. Feuer’s professional career, she has developed significant expertise working with boards of directors of both financial institutions and major companies and has extensive knowledge of public offerings and underwriting, as well as raising and managing private equity funds.
Also according to the 8K, “on November 8, 2018, the Registrant was granted a Certificate of Patent, #2015101908 (the “Innovation Patent”) from the Commissioner of Patents, Commonwealth of Australia, for the Registrant’s proprietary cream for the treatment of skin disorders. The Registrant’s skin cream has been proven, pre-clinically, to lower various inflammatory markers by up to 70% and to inhibit Keratocytes proliferation, a manifestation of various skin disorders, especially Psoriasis.”
Currently trading at a market capitalization of $66.4M, OWCP has a bankroll ($1.4M) of cash on the books, which compares with virtually no total current liabilities. OWCP is pulling in trailing 12-month revenues of $50K. However, the company is seeing a recent flattening of growth on the top-line on a sequential quarterly basis. You can bet we will update this one again as new information comes into view.
________________________
AbleBody, you are correct when you say this is consolidation. As I have mentioned, I anticipate being in this .070 - .085 range until financials are completed and disclosed. We may go higher depending on what news comes out and when. If you are a long,,,your good to go! Once the audit is complete, this stock will ROCK!!!
It looks like Steve had the vision back before the rest of us. A lot of lives could have been spared had he the backing he has today.
Pretty busy here as well although I have been able to get out before dark to fish. And well there is golf. I guess I haven't been nearly as busy as I feel I am. LOL
I hope your trades are working out well. I did put Mankind up as I saw the chart looked great. When I bought, I put in a $3.26 sell order but then took it down. I hope that wasn't a mistake. We will see.
Good luck Fitz!
Got it. I am more familiar with the shares traded,,,not the $ amount.
My point was that the Price Per Share will remain in this trading range until the revenues which Steve tweets are verified by the audit.
That, of course, is my opinion.
What was over 300K traded today? Shares?
I am convinced that until the revenues are audited and the sales are in fact verified as real we will see the PPS around this level. I am in a long position with ONCI and have faith in what Steve is telling us, however until it becomes certified, we will not see big money flow into this company and we will continue to see the MM's have their way with the PPS. I was fortunate enough to have hopped on the cheap train early this morning to pick up shares at a price I haven't seen for quite some time. Good luck to all holding (including me)
NITE and CDEL are pretty big but it just seems as if VNDM shows here a good bit. They all trade with each other to screw whichever ticker they have taken a liking to.
I agree Insta,,this is just one of those days. Wild swings,,,I was really lucky and bought myself a great Christmas gift.
$MNKD,,, in @ $3.12,,, we will see how it goes from here
$MNKD,,,glad I waited. This had 30K shares traded prior to the opening and drove the opening price to $3.25 per. By 9:38 the PPS was back to $3.13 per. Just waiting now for a good entry.
$MNKD,,,I like looking at stocks which I have had past plays on and this was no different. I pulled up the charts yesterday and noticed that it is prime to move based on the technical indicators I use. I played this on the way up just a month ago, before it tanked. Before I finally fell asleep last night, I pulled up MNKD on Stocktwits and saw a lot of negative posts which had me wondering. However, this morning I found this article which made me feel a little better.
https://www.smarteranalyst.com/2017/11/27/quant-king-david-shaw-pours-money-biotech-valeant-pharmaceuticals-intl-inc-vrx-mannkind-corporation-mnkd/
When I buy a position I will take profits, sometimes very quickly. Mankind will be on my radar when the market opens. If things are looking good for a continuation of yesterday, I will put in my order. If it looks like folks are taking their profits from yesterday, I will wait.
As I mentioned in my last email on MNKD, it appears this is primed to head north. All in my own opinion. Good luck trading.
$MNKD,, great day and chart is showing much more to come. In My Opinion, I see this at $4.15++ by next week. Opened today at $2.86 and closed the day at $3.16 (+9.72%). Nice green volume today and 5.5M shares were traded. All of the indicators I use are now extremely positive and just now coming off oversold positions. Good luck trading and use sense on entries and exits.
I thought November would be the start of a large catalyst for ONCI. I began questioning myself but there ARE two days remaining. I am the proverbial optimist and if Steve comes out with even half of which we all know he is holding, November just may be the start,,,yet.
Looking to close even. Nice profit from .082 today.
I am betting on you as well mikeyt, picked up a large position (additional) throughout the day. Gotta love it! Great stuff!!!
That's a great board Zblue. Discusses issues rationally and you don't have to put up with issues like whether the letterhead looks crooked or not.
I can't believe this is even an issue here. ONCI has an agreement with Mazars to perform the FINS. Berdboy, if you feel Steve has lied about that, you need to sell whatever ONCI shares you have and find a company with a CEO you can trust. Good luck with that!!!
10Q and Management Discussion:
https://www.marketwatch.com/story/10-q-green-spirit-industries-inc-2017-11-13
And you blame him,,,why?
Could be that Steve is holding onto the news waiting for the 'strawbacks' to sell. Get the day traders and flippers out at losses before putting out an incredible PR to shoot this to $.016. I would love it.
Or, just taking a break until after the weekend.
I have a nice position in this. I have the patience to wait.
Yeah, I know what you mean. I track 122 BioPharm stocks everyday so the time off will put me back where I need to be for those stocks.
I couldn't have said it better CoinPadawan! It's on it's way to be a heavyweight.
I Hope Everyone, yes including both BTW and CUZ, Have a Wonderful and Happy Holiday! Lots to be thankful for! Enjoy, eat too much then kick back for some football.
Thanks, and you are correct about everything. Have a great holiday.
I can live with this!
1 Month 6 Months 1 Year
ONCI: +11.70% +1,650.00% +1,066.67%
S&P 500 +1.16% +8.36% +18.24%
S&P Global BMI+0.85% +9.13% +21.49%
ep,,,plenty of them. Thanks Ms Cleo but I put my trust in my magic 8 ball. I asked if ONCI would exceed .02 this year "count on it".
Yep, he can't be beat. It's just a game and you better hope you are on his side. He won't get .007 (imo) but will get the .01. It all depend what he is in the mood for, he could drop down and pick up the .007, hopeing to cause a real panic sell-off, or he could wait for someone to buy the 10k at .01 (or pick it up himself) As I said 'he can't be beat.'
That makes complete sense,,, now he will buy it driving the price up (he hopes),,,then just start all over. Thanks Buckeye!!!